Michael J. Thirman

10.3k citations
90 papers · 4.0k · 2 hit papers · h-index 36

Impact in

  • Hematology top 0.2%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 1%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 52
    • Chronic Myeloid Leukemia Treatments 21
    • Protein Degradation and Inhibitors 12
    • Histone Deacetylase Inhibitors Research 9
    • RNA Interference and Gene Delivery 9
    • Retinoids in leukemia and cellular processes 8

Michael J. Thirman

88 papers receiving 3.9k citations

Michael J. Thirman's Hit Papers

Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine 2024 · 47 citations
470+2+5Years since publication100200300400

Peers

Michael J. Thirman
Comparison fields: 5 of 106
  • Hematology 2.4k
  • Genetics 671
  • Molecular Biology 2.3k
  • Public Health, Environmental and Occupational Health 775
  • Cancer Research 325
Replace Eyal C. Attar with:
Eyal C. Attar United States
Florian H. Heidel Germany
José Cervera Spain
Véronique Mansat‐De Mas France
Hélène Lapillonne France
Beatrice U. Mueller Switzerland
Sophie Park France
Masaharu Sakurai Japan
Felicetto Ferrara Italy
Rosangela Invernizzi Italy
Michael J. Thirman relative to Eyal C. Attar United States Eyal C. Attar's profile →
Citations per field
00.5×1.5×1.8×
Eyal C. Attar · 1×
Citations per year

Countries citing papers authored by Michael J. Thirman

Since Specialization
Citations

This map shows the geographic impact of Michael J. Thirman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Thirman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Thirman more than expected).

Fields of papers citing papers by Michael J. Thirman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Thirman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Thirman. The network helps show where Michael J. Thirman may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael J. Thirman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael J. Thirman Line = papers co-authored together Michael J. Thirman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
Hit paper breakdown →
2018498
2 1993413
3 1994187
4 1996128
5 2000112
6 2010111
7 2005107
8 2020103
9 201198
10 202195
11 199295
12 200692
13 201184
14 200180
15 200280
16 200174
17 200368
18 200567
19 200463
20 202259

About Michael J. Thirman

Michael J. Thirman is a scholar working on Hematology, Molecular Biology, Genetics, Public Health, Environmental and Occupational Health and Oncology, having authored 90 papers that have together received 4.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (52 papers), Chronic Lymphocytic Leukemia Research (21 papers), Chronic Myeloid Leukemia Treatments (21 papers), Acute Lymphoblastic Leukemia research (17 papers), Protein Degradation and Inhibitors (12 papers), Histone Deacetylase Inhibitors Research (9 papers), RNA Interference and Gene Delivery (9 papers) and Retinoids in leukemia and cellular processes (8 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (671 citations), Molecular Biology (2.3k citations), Public Health, Environmental and Occupational Health (775 citations) and Cancer Research (325 citations). Michael J. Thirman has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Richard A. Larson, Janet D. Rowley, Roger Luo, Hirofumi Kobayashi, Andrew Artz, Federico Simone, Jalaja Potluri, Keith W. Pratz, Courtney D. DiNardo and Daniel A. Pollyea. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, Journal of Clinical Oncology, Genes Chromosomes and Cancer and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact